Torrent Pharmaceuticals’ India bet is yielding rich dividends1 min read . Updated: 28 Feb 2019, 10:39 PM IST
- Market share gains in key brands and expansion in market presence are seen to be growth drivers in India
- The stock is up 31% in the last one year as investors began to see the benefits of the company’s last acquisition
Acquisitions are loaded with risks, especially in the pharmaceuticals industry. But even with as many as five acquisitions in four years, Torrent Pharmaceuticals Ltd has navigated these challenges rather well. Revenues at the company have risen 9.5% per annum on average over the last four fiscal years, at a time when many Indian pharma firms hit growth headwinds in recent years. Tracking the growth in revenues, the Torrent Pharma stock on average gained 23% per annum in FY15-FY18. It continues to do well.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started
Select your Category